Stage II melanoma requires careful treatment planning that depends on tumor thickness and skin characteristics. While surgery remains the cornerstone of care, recent advances have introduced new options designed to reduce the risk of cancer returning, marking an important shift in how doctors approach this stage of the disease.

How Treatment Aims to Keep You Healthy

When you receive a diagnosis of stage II melanoma, understanding your treatment options becomes one of the most important steps in your journey. The main goal of treatment at this stage is to remove the cancer completely and reduce the chance that it will come back or spread to other parts of your body. Stage II melanoma means the cancer has grown deeper into your skin layers but has not yet reached your lymph nodes or other organs, which offers a real opportunity for successful treatment outcomes.^[1]

Your treatment plan will be shaped by several factors, including how thick the melanoma tumor is, whether the top layer of skin over the melanoma looks broken or intact when examined under a microscope (a feature called ulceration), your overall health, and where the melanoma is located on your body. Doctors also consider your age and personal preferences when recommending the best approach for your situation.^[2]

Medical societies have established treatment guidelines based on years of research and patient experiences. These guidelines help doctors determine which patients might benefit from surgery alone and which might need additional treatment afterward. At the same time, researchers continue to study new therapies in clinical trials, searching for better ways to prevent melanoma from returning. This combination of proven standard treatments and promising experimental approaches gives patients more options than ever before.^[10]

Understanding Stage II Melanoma

Stage II melanoma is divided into three substages that help doctors predict risk and plan treatment more precisely. Stage IIA melanoma includes tumors that are more than 1 millimeter but less than 2 millimeters thick with ulceration, or tumors between 2 and 4 millimeters thick without ulceration. Stage IIB melanoma involves tumors between 2 and 4 millimeters thick with ulceration, or tumors thicker than 4 millimeters without ulceration. Stage IIC melanoma means the tumor is more than 4 millimeters thick and has ulceration present.^[1]

These measurements matter because they directly relate to your risk of the cancer coming back. Research looking at medical records of patients with stage IIB melanoma who chose to “watch and wait” after surgery found that 37% of people had their cancer return, and in half of those cases, the cancer spread to other parts of the body. For stage IIC melanoma, 43% experienced recurrence, with 58% of those having cancer spread to distant sites. These numbers help explain why doctors now recommend discussing additional treatment options beyond surgery for patients with stage IIB and IIC disease.^[13]

Standard Treatment: Surgery as the Foundation

Surgery is the main treatment for all patients with stage II melanoma. The procedure, called wide local excision, involves removing a larger area of skin around where the melanoma was originally found. This is not just removing the visible tumor – doctors take out a margin of healthy-looking skin surrounding the site to make sure any cancer cells that might have spread into nearby tissue are also removed.^[2]

The amount of skin your surgeon removes depends on how thick your melanoma was. For thinner melanomas, the margin might be smaller, while thicker tumors require wider margins to ensure complete removal. This surgery is typically performed as an outpatient procedure, meaning you can go home the same day. The removed tissue is sent to a laboratory where a specialist examines it under a microscope to confirm that all cancer cells have been cleared from the edges.^[1]

Many doctors also recommend a procedure called sentinel lymph node biopsy at the same time as the wide local excision. This test checks whether any melanoma cells have traveled to the nearest lymph nodes. During this procedure, your doctor identifies the first lymph node or nodes that fluid from the melanoma site would drain into. These sentinel nodes are removed and examined for cancer cells. If cancer is found in the lymph nodes, your stage changes to stage III, which would alter your treatment plan. If you don’t have a sentinel lymph node biopsy, your doctor might ask you to have regular ultrasound scans of your lymph nodes to watch for any changes.^[2]

The surgery itself is generally well-tolerated. Your surgeon will use local or general anesthesia depending on the size and location of the area being removed. After surgery, you’ll have stitches and a scar, but your surgical team will work to minimize scarring as much as possible. Recovery time varies depending on the size of the excision, but most people return to normal activities within a few weeks. You’ll need to keep the area clean and watch for signs of infection while it heals.^[9]

Treatment After Surgery: A New Option for High-Risk Patients

For many years, surgery was the only treatment offered to patients with stage II melanoma. However, recent clinical trial results have changed this approach. Doctors now may recommend additional treatment after surgery, called adjuvant therapy, for patients with stage IIB or IIC melanoma. Adjuvant means “helping” – these treatments are designed to help prevent the melanoma from coming back or spreading after the tumor has been removed.^[2]

The decision to receive adjuvant therapy is personal and complex. Your doctor will discuss the chance of your melanoma returning based on your specific tumor characteristics, balanced against the potential side effects of treatment. Some patients with stage IIA melanoma also worry about their risk of recurrence, and while adjuvant therapy is not currently standard for this substage, these patients should discuss their concerns and individual risk factors with their medical team.^[6]

The most common adjuvant treatment currently recommended for stage IIB and IIC melanoma is an immunotherapy drug called pembrolizumab (brand name Keytruda). Pembrolizumab belongs to a class of drugs called checkpoint inhibitors. These medications work by helping your own immune system recognize and attack cancer cells. Normally, cancer cells can hide from the immune system by using certain proteins as a disguise. Pembrolizumab blocks one of these proteins, called PD-1, allowing your immune cells to see and destroy any remaining melanoma cells in your body.^[2]

Another immunotherapy drug called nivolumab works in a similar way by blocking the same PD-1 protein. Clinical trials have shown that both pembrolizumab and nivolumab can reduce the risk of melanoma returning after surgery in patients with high-risk stage II disease. These represent important advances because they give patients with stage II melanoma access to treatments that have already proven effective in more advanced stages of melanoma.^[10]

How Adjuvant Immunotherapy Is Given

If you and your doctor decide that adjuvant immunotherapy is right for you, you’ll receive the treatment as an infusion through a vein in your arm. Pembrolizumab is typically given every three weeks as a 30-minute infusion. The standard treatment duration in clinical trials was approximately one year, though your doctor will tailor the treatment plan to your specific situation.^[13]

You don’t need to stay in the hospital for these treatments. Most people come to an infusion center or their doctor’s office, receive the treatment, and go home the same day. You’ll be monitored during the infusion to watch for any immediate reactions. Before each treatment session, you may have blood tests to check your overall health and make sure your body is tolerating the therapy well.

It’s important to keep all your scheduled appointments and not miss doses. The effectiveness of immunotherapy depends on maintaining consistent treatment according to the schedule your doctor prescribes. If you experience side effects between treatments, contact your medical team right away – they may need to adjust your treatment plan or provide medications to help manage symptoms.^[13]

Understanding Side Effects of Immunotherapy

While immunotherapy has transformed melanoma treatment, it can cause side effects because it activates your immune system. The most common side effects include fatigue, which can make you feel more tired than usual, skin rash or itching, and diarrhea. Some patients experience muscle or joint aches, fever, or flu-like symptoms. These side effects often start during the first few months of treatment but can occur at any time.^[10]

More serious side effects can occur when the activated immune system attacks healthy organs. These immune-related side effects can affect the lungs, causing inflammation and breathing problems; the liver, leading to abnormal liver function; the intestines, resulting in severe diarrhea or abdominal pain; or hormone-producing glands like the thyroid or pituitary. The immune system can also affect the kidneys, skin, joints, or nervous system. While these serious side effects are less common, they require immediate medical attention.^[10]

Your healthcare team will teach you which symptoms to watch for and when to call them. Many side effects can be managed with medications like steroid pills that calm down the overactive immune system. In some cases, if side effects are severe, your treatment may need to be delayed or stopped. The good news is that most patients who experience side effects can have them successfully managed, allowing them to continue with treatment.

Clinical Trial Results That Changed Practice

The decision to offer immunotherapy to patients with stage IIB and IIC melanoma was based on results from important clinical trials. In one major study called KEYNOTE-716, researchers compared 487 people who received pembrolizumab after surgery to 489 people who received a placebo (an inactive treatment). The patients receiving pembrolizumab had better outcomes – at the time of follow-up, 89% of people who received pembrolizumab did not have their melanoma return, compared to 83% of those who received placebo.^[13]

Looking specifically at whether the cancer spread to other parts of the body, 87% of patients who received pembrolizumab after surgery did not have their melanoma spread to distant sites, compared to 81% of those who received placebo. These results show that pembrolizumab can meaningfully reduce the risk of melanoma coming back and spreading, which is why medical organizations now recommend discussing this option with eligible patients.^[13]

Another important trial called CheckMate 76K studied nivolumab in a similar way and also found improved outcomes for patients who received the immunotherapy compared to those who didn’t. These trials specifically included patients aged 12 years and older who had stage IIB or IIC melanoma completely removed by surgery. The success of these trials led to regulatory approval of these treatments in the United States and other countries.^[10]

It’s important to understand that these trials measured recurrence-free survival – meaning the time patients lived without their cancer coming back. The trials have not yet shown whether adjuvant immunotherapy helps patients live longer overall, because that requires many more years of follow-up. Researchers continue to track these patients over time to answer this important question.^[13]

Ongoing Research and Future Treatment Possibilities

Beyond the immunotherapy drugs already approved, researchers are actively studying other promising approaches in clinical trials for stage II melanoma. These trials are investigating different types of treatments, new combinations, and innovative strategies to prevent melanoma from returning.

Some clinical trials are testing whether combining two different immunotherapy drugs works better than using just one. For example, researchers are studying combinations of drugs that block different checkpoint proteins on immune cells. The theory is that attacking cancer cells from multiple angles might be more effective, though it could also increase side effects. These trials are still in progress, and it will take time to know whether combination approaches offer advantages.^[10]

Other researchers are investigating whether shorter durations of immunotherapy might work just as well as the standard one-year treatment course but with fewer side effects. Some trials are comparing six months of treatment versus twelve months, while others are exploring whether certain patients might benefit from longer treatment periods. These studies aim to find the optimal balance between effectiveness and tolerability.

Scientists are also working on developing blood tests that could help predict which patients are at highest risk of their melanoma returning. These tests, which look for circulating tumor DNA (tiny fragments of tumor material in the blood), might help doctors identify patients who would benefit most from adjuvant therapy. Similarly, researchers are studying whether certain characteristics of the tumor itself, such as specific genetic mutations or immune system markers, can predict response to treatment. This personalized medicine approach could help tailor treatment recommendations to each individual patient in the future.^[10]

Clinical trials are the pathway through which new treatments become available. If you’re interested in participating in a clinical trial, talk with your doctor about whether any trials might be appropriate for your situation. Trials are conducted at cancer centers and hospitals throughout the United States, Europe, and other regions. Participating in a trial gives you access to cutting-edge treatments while contributing to medical knowledge that will help future patients.

Most common treatment methods

• Surgery
  • Wide local excision to remove melanoma tumor along with surrounding healthy tissue margin
  • Sentinel lymph node biopsy to check for cancer spread to nearby lymph nodes
  • Usually performed as outpatient procedure with local or general anesthesia
  • Surgery alone often cures stage II melanoma, particularly lower-risk cases
• Adjuvant Immunotherapy
  • Pembrolizumab (Keytruda) given as intravenous infusion every three weeks
  • Nivolumab administered similarly to pembrolizumab for high-risk stage II disease
  • Works by blocking PD-1 protein to help immune system recognize and attack cancer cells
  • Recommended for stage IIB and IIC melanoma after complete surgical removal
  • Treatment typically continues for approximately one year
  • Reduces risk of melanoma recurrence and spread based on clinical trial data
• Active Surveillance
  • Regular monitoring with physical examinations by dermatologist or oncologist
  • Periodic ultrasound imaging of lymph nodes if sentinel lymph node biopsy not performed
  • Patient education about self-examination and warning signs of recurrence
  • May be chosen instead of adjuvant therapy after discussion of individual risks and preferences

Your Care Team and Decision-Making

Treating stage II melanoma typically involves several different healthcare professionals working together. Your dermatologist may be the doctor who initially diagnosed your melanoma and might continue to monitor your skin for new melanomas or signs of recurrence. A surgeon, who might be a surgical oncologist, plastic surgeon, or dermatologic surgeon, will perform the wide local excision and potentially the sentinel lymph node biopsy. An oncologist specializes in cancer treatment and will discuss whether adjuvant therapy is appropriate for your situation, provide the treatment if you choose it, and monitor you for side effects.^[6]

You should feel comfortable asking your care team questions about your diagnosis, treatment options, and expected outcomes. Important topics to discuss include the specific substage of your melanoma, your individual risk of recurrence, what the surgery will involve and how long recovery takes, whether sentinel lymph node biopsy is recommended, the benefits and risks of adjuvant therapy in your case, and what follow-up care will look like. Your doctors should explain all options clearly and help you make informed decisions that align with your values and preferences.^[21]

Some patients find it helpful to seek a second opinion, particularly when facing decisions about adjuvant therapy. This is completely appropriate and many doctors encourage it. A second opinion from another melanoma specialist can provide additional perspective and help you feel confident about your treatment plan. Most insurance plans cover second opinions, though you should check with your specific plan.

Follow-Up Care and Monitoring

After completing treatment for stage II melanoma, you’ll need regular follow-up appointments to check for any signs that the cancer has returned or that a new melanoma has developed. The frequency of these visits typically depends on your specific stage and risk factors. Initially, you might see your doctor every three to six months, with the time between visits gradually increasing if everything remains stable.^[19]

During follow-up visits, your doctor will examine your skin thoroughly, check your lymph nodes, and ask about any new symptoms. You may have imaging tests like chest X-rays, CT scans, or PET scans at certain intervals, especially in the first few years after treatment when recurrence risk is highest. Some doctors recommend regular ultrasound examinations of the lymph node areas to look for early signs of spread.

You play an important role in your own monitoring by performing regular skin self-examinations. Your healthcare team should teach you how to check your entire body systematically, looking for new spots or changes in existing moles. You should examine your skin about once a month in good lighting, using mirrors to see hard-to-view areas. If you notice anything suspicious – a new growth, a sore that doesn’t heal, or changes in a mole – contact your doctor promptly rather than waiting for your next scheduled appointment.^[18]

Having had one melanoma increases your risk of developing another one, so protecting your skin from sun exposure becomes even more important. Use a broad-spectrum sunscreen with SPF 50 or higher on exposed skin, wear protective clothing including wide-brimmed hats and long sleeves when outdoors, avoid tanning beds completely, and try to stay out of direct sun during peak intensity hours between 11 AM and 3 PM. These sun protection measures significantly reduce your risk of developing new melanomas.^[18]

Living With and Beyond Stage II Melanoma

A melanoma diagnosis affects more than just your physical health – it can impact your emotional well-being, relationships, and daily life. Many people experience anxiety about the cancer returning, which is a normal response. Talking with your healthcare team, joining a support group with other melanoma patients, or working with a mental health professional can help you process these feelings and develop coping strategies.

Some patients find that staying physically active and maintaining a healthy lifestyle helps them feel more in control. While there’s no specific diet proven to prevent melanoma recurrence, eating a balanced diet rich in fruits and vegetables, staying at a healthy weight, exercising regularly, avoiding tobacco, and limiting alcohol consumption support your overall health and may help your body recover from treatment.

Your healthcare team should discuss vitamin D with you. Sun exposure is the main source of vitamin D for most people, but you need to balance the vitamin D benefits against the risk of further sun damage. Medical organizations recommend that everyone diagnosed with melanoma have a blood test to measure vitamin D levels. If your levels are low, your doctor may recommend vitamin D supplements or suggest dietary sources like oily fish, eggs, and fortified foods.^[18]

Looking forward, many people successfully complete treatment for stage II melanoma and live long, healthy lives. The treatments available today, including adjuvant immunotherapy, have improved outcomes for patients with high-risk disease. Continuing research promises even better treatments in the future. By working closely with your healthcare team, staying vigilant about your skin health, and taking care of your overall well-being, you’re taking important steps toward the best possible outcome.